RG

Riman Gupta

Active Director Director DIN 11242260
DIN 11242260 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Riman Gupta

Data last updated:

Riman Gupta is a Director at Harasha Pharma Private Limited (since 2025). The company operates in Healthcare. Harasha Pharma Private Limited reported revenue of ₹17.49 Cr (FY 2025).

DIN 11242260
Primary Designation Director
Industry Healthcare
First Appointment 13 Aug 2025
Oldest Company Age 29 yrs
Largest company Harasha Pharma Private Limited · ₹17.49 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Harasha Pharma Private Limited U02423DL1997PTC084196
Director13 Aug 20251997₹17.49 Cr (FY 2025)Active

Board colleagues of Riman Gupta

NameDINCompanyDesignation
Monika Singla01627938Harasha Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Harasha Pharma Private Limited
Premium access

Shareholding and investment profile for Riman Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Riman Gupta

Riman Gupta currently holds 1 directorship: Harasha Pharma Private Limited (Director, since 13 Aug 2025, revenue ₹17.49 Cr (FY 2025)).

Riman Gupta was first appointed on 13 Aug 2025 as Director at Harasha Pharma Private Limited.

The current boards of Riman Gupta's companies include Monika Singla (Harasha Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available